Nateglinide |
Nateglinide Products |
| [beta]-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.(Pathophysiology/Complications) : An article from: Diabetes Care Andrea Mari, Amalia Gastaldelli, James E. Foley, Richard E. Pratley, Ele Ferrannini American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|
| Preserve-[beta]: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.(Clinical Care/Education/Nutrition) : An article from: Diabetes Care John Gerich, Philip Raskin, Lisa Jean-Louis, Das Purkayastha, Michelle A. Baron Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Oral antiglycemic agents compared in two trials. (Expert Questions Design of Studies).(Repaglinide and nateglinide for type 2 diabetes): An article from: Family Practice News Doug Brunk International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Repaglinide outperforms nateglinide in two trials: type 2 diabetes.(Rx): An article from: Internal Medicine News Doug Brunk International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control. (Clinical Care/Education/Nutrition). : An article from: Diabetes Care Vivian Fonseca, George Grunberger, Shamita Gupta, Sharon Shen, James E. Foley American Diabetes Association American Diabetes Association |
Sale Price: $5.95
|

Not Signed In - 


